Medical management of side effects related to CAR T cell therapy in hematologic malignancies

Chimeric antigen receptor (CAR) T cells are genetically modified T cells, which by design, combine the advantage of human leukocyte antigen (HLA)-independent antigen recognition with the cytotoxic ...